ViewRay MRIdian Linac System: Model No. 20000-01 software, CE 0086 - Product Usage: intended to ...
FDA Device Recall #Z-1836-2021 — Class II — May 4, 2021
Recall Summary
| Recall Number | Z-1836-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | May 4, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Viewray, Inc. |
| Location | Mountain View, CA |
| Product Type | Devices |
| Quantity | 8 versions |
Product Description
ViewRay MRIdian Linac System: Model No. 20000-01 software, CE 0086 - Product Usage: intended to be used for planning external beam irradiation with photon beams and delivering stereotactic radiosurgery and precision radiotherapy for lesions, tumors, and conditions anywhere in the body when radiation treatment is indicated, in conjunction with the ViewRay System, an MRI image-guided radiation therapy system.
Reason for Recall
Software anomalies affecting the French, German and Italian versions of treatment delivery system (TDS) software.
Distribution Pattern
International distribution only to the countries of France, Germany, Italy, and Switzerland.
Lot / Code Information
French version of the TDS software affected serial numbers: 214, 215, 226 and 240 German or Italian versions of the TDS software affected serial numbers: 203, 232, 108 and 244
Other Recalls from Viewray, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0481-2021 | Class II | ViewRay MRIdian System: Model No. 10000, CE, R... | Oct 20, 2020 |
| Z-0482-2021 | Class II | ViewRay MRIdian Linac System: Model No. 20000,... | Oct 20, 2020 |
| Z-1803-2020 | Class II | ViewRay System: Model No. 10000 and 20000 for r... | Nov 18, 2019 |
| Z-1251-2019 | Class II | MRIdian Linac Radiation Therapy System, Model 2... | Mar 18, 2019 |
| Z-0676-2020 | Class II | MRIdian Linac Radiation Therapy System Model 10... | Mar 3, 2019 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.